ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,357.30
0.08%
US Tech 100
18,539.60
0.03%
Dow Jones
38,925.68
0.10%
Brent Oil
79.405
-0.59%
Bitcoin
69,072.00
-2.40%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. PepGen Inc (PEPG) Quote

PepGen Inc

PepGen Inc (PEPG)

PepsiCo Inc
17.005
-0.335
( -1.93% )
Updated: 14:42:48
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
17.005
Bid
16.84
Ask
17.05
Volume
6,048
16.85 Day's Range 17.19
3.72 52 Week Range 18.3487
Market Cap
550.026M
Previous Close
17.34
Open
17.04
Last Trade
14
@
16.86
Last Trade Time
14:42:45
Financial Volume
$ 103,173
VWAP
17.0591
Average Volume (3m)
74,762
Shares Outstanding
32,354,495
Dividend Yield
-
PE Ratio
-7.00
Earnings Per Share (EPS)
-2.43
Revenue
-
Net Profit
-78.63M

About PepGen Inc

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
pepgen.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
PepGen Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PEPG. The last closing price for PepGen was $17.34. Over the last year, PepGen shares have traded in a share price range of $ 3.72 to $ 18.3487.

PepGen currently has 32,354,495 shares outstanding. The market capitalization of PepGen is $550.03 million. PepGen has a price to earnings ratio (PE ratio) of -7.00.

PEPG Latest News

More News

Form 144 - Report of proposed sale of securities

June 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 17 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

May 17 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14 2024
Edgar (US Regulatory)

PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

– CONNECT1-EDO51 trial preliminary data from 5mg/kg dose cohort expected mid-2024 – – FREEDOM1-DM1 trial preliminary data from at least 5mg/kg dose cohort expected second half 2024 – – Net...

May 14 2024
GlobeNewswire Inc.

Form 8-K - Current report

May 14 2024
Edgar (US Regulatory)

PepGen to Participate in Upcoming Investor Conferences

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of...

March 13 2024
GlobeNewswire Inc.

PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of...

March 13 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.4052.4397590361416.618.348715.017686116.81391084CS
43.43525.313190862213.5718.348712.37410415.0645038CS
123.23523.493100944113.7718.348710.2157476214.05517693CS
2610.595165.2886115446.4118.34875.419921912.60140313CS
520.5253.1856796116516.4818.34873.728102910.32817431CS
1561.4059.0064102564115.6203.7210199311.2845785CS
2601.4059.0064102564115.6203.7210199311.2845785CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEROVenus Concept Inc
$ 1.07
(82.38%)
65.53M
AONCAmerican Oncology Network Inc
$ 2.77
(62.94%)
4.17M
CLEUChina Liberal Education Holdings Ltd
$ 3.06
(51.49%)
14.85M
PRSTPresto Technologies Inc
$ 0.1144
(50.72%)
249.35M
HUDAHudson Acquisition I Corporation
$ 14.00
(27.85%)
486.87k
DSYBig Tree Cloud Holdings Limited
 1.82
(-75.86%)
308.89k
BMEABiomea Fusion Inc
$ 4.005
(-64.46%)
9.44M
SHOTWSafety Shot Inc
$ 0.2169
(-42.91%)
557
NBSTWNewbury Street Acquisition Corporation
$ 0.0373
(-32.18%)
173.7k
SCNIScinai Immunotherapeutics Ltd
$ 2.9001
(-30.10%)
654.62k
FFIEFaraday Future Intelligent Electric Inc
$ 0.621299
(14.21%)
390.8M
PRSTPresto Technologies Inc
$ 0.114
(50.20%)
249.4M
CRKNCrown Electrokinetics Corporation
$ 0.08965
(2.57%)
109.1M
SQQQProShares UltraPro Short QQQ
$ 9.32
(0.32%)
93.63M
GERNGeron Corp
$ 4.64
(19.28%)
80.3M

PEPG Discussion

View Posts
Monksdream Monksdream 3 months ago
PEPG 10Q due 3/22
👍️0
Monksdream Monksdream 4 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0

Your Recent History

NASDAQ
PEPG
PepGen
EU
Q439S
Q439S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved